NM_002838.5:c.1297G>A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_002838.5(PTPRC):c.1297G>A(p.Asp433Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,611,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002838.5 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 104Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- T-B+ severe combined immunodeficiency due to CD45 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000986 AC: 150AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000891 AC: 223AN: 250260 AF XY: 0.000856 show subpopulations
GnomAD4 exome AF: 0.00108 AC: 1573AN: 1459212Hom.: 0 Cov.: 31 AF XY: 0.00100 AC XY: 729AN XY: 725940 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000986 AC: 150AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000969 AC XY: 72AN XY: 74296 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
The PTPRC c.1297G>A; p.Asp433Asn variant (rs140403368), to our knowledge, is not reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.09% (identified on 259 out of 276,470 chromosomes) and is classified as a variant of unknown significance in ClinVar (ID: 464439). The aspartic acid at position 433 is weakly conserved, considering 12 species, and computational analyses of the effects of the p.Asp433Asn variant on protein structure and function do not predict a deleterious effect (SIFT: tolerated, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Asp433Asn variant cannot be determined with certainty. -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Immunodeficiency 104 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 433 of the PTPRC protein (p.Asp433Asn). This variant is present in population databases (rs140403368, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PTPRC-related conditions. ClinVar contains an entry for this variant (Variation ID: 464439). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
PTPRC-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at